The efficacy of paxlovid in elderly patients infected with SARS-CoV-2 omicron variants: Results of a non-randomized clinical trial

OBJECTIVE: To evaluate the efficacy of Paxlovid in treating Chinese elder patients infected with SARS-CoV-2 omicron variants. MATERIALS AND METHODS: We performed a non-randomized, controlled trial in Shanghai, China. Participants infected with SARS-CoV-2 omicron variants were enrolled. All patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Weijie, Jiang, Xiufeng, Yang, Xiaosheng, Feng, Tiantong, Duan, Zhixin, Wang, Wei, Sun, Zhaoliang, Chen, Lingyan, Nie, Xin, Zhu, Chuanlong, Zhang, Wenchuan, Li, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9485497/
https://www.ncbi.nlm.nih.gov/pubmed/36148451
http://dx.doi.org/10.3389/fmed.2022.980002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9485497/
https://www.ncbi.nlm.nih.gov/pubmed/36148451
http://dx.doi.org/10.3389/fmed.2022.980002

Ejemplares similares